This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mauser, A.
Right arrow Articles by Kenney, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mauser, A.
Right arrow Articles by Kenney, S.

 Previous Article  |  Next Article 

Journal of Virology, December 2002, p. 12503-12512, Vol. 76, No. 24
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.24.12503-12512.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

The Epstein-Barr Virus Immediate-Early Protein BZLF1 Regulates p53 Function through Multiple Mechanisms

Amy Mauser,1 Shin'ichi Saito,2 Ettore Appella,2 Carl W. Anderson,3 William T. Seaman,1 and Shannon Kenney1,4,5*

Lineberger Comprehensive Cancer Center,1 Department of Medicine,4 Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, North Carolina 27599,5 Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892,2 Biology Department, Brookhaven National Laboratory, Upton, New York 119733

Received 13 March 2002/ Accepted 11 September 2002

The Epstein-Barr virus (EBV) immediate-early protein BZLF1 is a transcriptional activator that mediates the switch between the latent and the lytic forms of EBV infection. It was previously reported that BZLF1 inhibits p53 transcriptional function in reporter gene assays. Here we further examined the effects of BZLF1 on p53 function by using a BZLF1-expressing adenovirus vector (AdBZLF1). Infection of cells with the AdBZLF1 vector increased the level of cellular p53 but prevented the induction of p53-dependent cellular target genes, such as p21 and MDM2. BZLF1-expressing cells had increased p53-specific DNA binding activity in electrophoretic mobility shift assays, increased p53 phosphorylation at multiple residues (including serines 6, 9, 15, 33, 46, 315, and 392), and increased acetylation at lysine 320 and lysine 382. Thus, the inhibitory effects of BZLF1 on p53 transcriptional function cannot be explained by its effects on p53 phosphorylation, acetylation, or DNA binding activity. BZLF1 substantially reduced the level of cellular TATA binding protein (TBP) in both normal human fibroblasts and A549 cells, and the inhibitory effects of BZLF1 on p53 transcriptional function could be partially rescued by the overexpression of TBP. Thus, BZLF1 has numerous effects on p53 posttranslational modification but may inhibit p53 transcriptional function in part through an indirect mechanism involving the suppression of TBP expression.


* Corresponding author. Mailing address: Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599-7295. Phone: (919) 966-1248. Fax: (919) 966-8212. E-mail: shann{at}med.unc.edu.


Journal of Virology, December 2002, p. 12503-12512, Vol. 76, No. 24
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.24.12503-12512.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Hwang, E.-S., Zhang, Z., Cai, H., Huang, D. Y., Huong, S.-M., Cha, C.-Y., Huang, E.-S. (2009). Human Cytomegalovirus IE1-72 Protein Interacts with p53 and Inhibits p53-Dependent Transactivation by a Mechanism Different from That of IE2-86 Protein. J. Virol. 83: 12388-12398 [Abstract] [Full Text]  
  • Bailey, S. G., Verrall, E., Schelcher, C., Rhie, A., Doherty, A. J., Sinclair, A. J. (2009). Functional Interaction between Epstein-Barr Virus Replication Protein Zta and Host DNA Damage Response Protein 53BP1. J. Virol. 83: 11116-11122 [Abstract] [Full Text]  
  • Tsai, S.-C., Lin, S.-J., Chen, P.-W., Luo, W.-Y., Yeh, T.-H., Wang, H.-W., Chen, C.-J., Tsai, C.-H. (2009). EBV Zta protein induces the expression of interleukin-13, promoting the proliferation of EBV-infected B cells and lymphoblastoid cell lines. Blood 114: 109-118 [Abstract] [Full Text]  
  • Chang, S.-S., Lo, Y.-C., Chua, H.-H., Chiu, H.-Y., Tsai, S.-C., Chen, J.-Y., Lo, K.-W., Tsai, C.-H. (2008). Critical Role of p53 in Histone Deacetylase Inhibitor-Induced Epstein-Barr Virus Zta Expression. J. Virol. 82: 7745-7751 [Abstract] [Full Text]  
  • Oster, B., Bundgaard, B., Hupp, T. R., Hollsberg, P. (2008). Human herpesvirus 6B induces phosphorylation of p53 in its regulatory domain by a CK2- and p38-independent pathway. J. Gen. Virol. 89: 87-96 [Abstract] [Full Text]  
  • Chang, P.-C., Li, M. (2008). Kaposi's Sarcoma-Associated Herpesvirus K-Cyclin Interacts with Cdk9 and Stimulates Cdk9-Mediated Phosphorylation of p53 Tumor Suppressor. J. Virol. 82: 278-290 [Abstract] [Full Text]  
  • Munoz-Fontela, C., Garcia, M. A., Collado, M., Marcos-Villar, L., Gallego, P., Esteban, M., Rivas, C. (2007). Control of virus infection by tumour suppressors. Carcinogenesis 28: 1140-1144 [Abstract] [Full Text]  
  • Guerreiro-Cacais, A. O., Uzunel, M., Levitskaya, J., Levitsky, V. (2007). Inhibition of Heavy Chain and {beta}2-Microglobulin Synthesis as a Mechanism of Major Histocompatibility Complex Class I Downregulation during Epstein-Barr Virus Replication. J. Virol. 81: 1390-1400 [Abstract] [Full Text]  
  • Tedeschi, R., Bloigu, A., Ogmundsdottir, H. M., Marus, A., Dillner, J., dePaoli, P., Gudnadottir, M., Koskela, P., Pukkala, E., Lehtinen, T., Lehtinen, M. (2007). Activation of Maternal Epstein-Barr Virus Infection and Risk of Acute Leukemia in the Offspring. Am J Epidemiol 165: 134-137 [Abstract] [Full Text]  
  • Chang, Y., Lee, H.-H., Chen, Y.-T., Lu, J., Wu, S.-Y., Chen, C.-W., Takada, K., Tsai, C.-H. (2006). Induction of the early growth response 1 gene by epstein-barr virus lytic transactivator zta.. J. Virol. 80: 7748-7755 [Abstract] [Full Text]  
  • Hong, G. K., Kumar, P., Wang, L., Damania, B., Gulley, M. L., Delecluse, H.-J., Polverini, P. J., Kenney, S. C. (2005). Epstein-Barr Virus Lytic Infection Is Required for Efficient Production of the Angiogenesis Factor Vascular Endothelial Growth Factor in Lymphoblastoid Cell Lines. J. Virol. 79: 13984-13992 [Abstract] [Full Text]  
  • Hong, G. K., Gulley, M. L., Feng, W.-H., Delecluse, H.-J., Holley-Guthrie, E., Kenney, S. C. (2005). Epstein-Barr Virus Lytic Infection Contributes to Lymphoproliferative Disease in a SCID Mouse Model. J. Virol. 79: 13993-14003 [Abstract] [Full Text]  
  • Adamson, A. L., Wright, N., LaJeunesse, D. R. (2005). Modeling Early Epstein-Barr Virus Infection in Drosophila melanogaster: The BZLF1 Protein. Genetics 171: 1125-1135 [Abstract] [Full Text]  
  • Al Mehairi, S., Cerasoli, E., Sinclair, A. J. (2005). Investigation of the Multimerization Region of the Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Protein K-bZIP: the Proposed Leucine Zipper Region Encodes a Multimerization Domain with an Unusual Structure. J. Virol. 79: 7905-7910 [Abstract] [Full Text]  
  • Liao, G., Huang, J., Fixman, E. D., Hayward, S. D. (2005). The Epstein-Barr Virus Replication Protein BBLF2/3 Provides an Origin-Tethering Function through Interaction with the Zinc Finger DNA Binding Protein ZBRK1 and the KAP-1 Corepressor. J. Virol. 79: 245-256 [Abstract] [Full Text]  
  • Ishii, H H, Gobe, G C, Yoneyama, J, Mukaide, M, Ebihara, Y (2004). Role of p53, apoptosis, and cell proliferation in early stage Epstein-Barr virus positive and negative gastric carcinomas. J. Clin. Pathol. 57: 1306-1311 [Abstract] [Full Text]  
  • Lin, Z., Yin, Q., Flemington, E. (2004). Identification of a Negative Regulatory Element in the Epstein-Barr Virus Zta Transactivation Domain That Is Regulated by the Cell Cycle Control Factors c-Myc and E2F1. J. Virol. 78: 11962-11971 [Abstract] [Full Text]  
  • Zheng, G., Yang, Y.-C. (2004). ZNF76, a Novel Transcriptional Repressor Targeting TATA-binding Protein, Is Modulated by Sumoylation. J. Biol. Chem. 279: 42410-42421 [Abstract] [Full Text]  
  • Boutell, C., Everett, R. D. (2004). Herpes Simplex Virus Type 1 Infection Induces the Stabilization of p53 in a USP7- and ATM-Independent Manner. J. Virol. 78: 8068-8077 [Abstract] [Full Text]  
  • Granja, A. G., Nogal, M. L., Hurtado, C., Salas, J., Salas, M. L., Carrascosa, A. L., Revilla, Y. (2004). Modulation of p53 Cellular Function and Cell Death by African Swine Fever Virus. J. Virol. 78: 7165-7174 [Abstract] [Full Text]  
  • Knight, J. S., Robertson, E. S. (2004). Epstein-Barr Virus Nuclear Antigen 3C Regulates Cyclin A/p27 Complexes and Enhances Cyclin A-Dependent Kinase Activity. J. Virol. 78: 1981-1991 [Abstract] [Full Text]  
  • Morrison, T. E., Mauser, A., Klingelhutz, A., Kenney, S. C. (2004). Epstein-Barr Virus Immediate-Early Protein BZLF1 Inhibits Tumor Necrosis Factor Alpha-Induced Signaling and Apoptosis by Downregulating Tumor Necrosis Factor Receptor 1. J. Virol. 78: 544-549 [Abstract] [Full Text]  
  • Fu, M., Rao, M., Wang, C., Sakamaki, T., Wang, J., Di Vizio, D., Zhang, X., Albanese, C., Balk, S., Chang, C., Fan, S., Rosen, E., Palvimo, J. J., Janne, O. A., Muratoglu, S., Avantaggiati, M. L., Pestell, R. G. (2003). Acetylation of Androgen Receptor Enhances Coactivator Binding and Promotes Prostate Cancer Cell Growth. Mol. Cell. Biol. 23: 8563-8575 [Abstract] [Full Text]  
  • Freie, B., Li, X., Ciccone, S. L. M., Nawa, K., Cooper, S., Vogelweid, C., Schantz, L., Haneline, L. S., Orazi, A., Broxmeyer, H. E., Lee, S.-H., Clapp, D. W. (2003). Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis. Blood 102: 4146-4152 [Abstract] [Full Text]  
  • Sinclair, A. J. (2003). bZIP proteins of human gammaherpesviruses. J. Gen. Virol. 84: 1941-1949 [Abstract] [Full Text]